GRM5 and Lewy body dementia: In PD or dementia with Lewy body (DLB) patients, or α-syn transgenic models, the accumulation of α-syn resulting in alterations of mGluR5, as well as interfering with mGluR5 trafficking, showed that mGluR5 plays a crucial role in α-synucleinopathies [18].